Cargando…

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β

OBJECTIVES: We aimed to investigate the association between polymorphisms located in type I interferon (IFN)-induced genes, genes belonging to the toll-like receptor (TLR) pathway, and genes encoding neurotransmitter receptors and the response to IFN-β treatment in patients with multiple sclerosis (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bustamante, Marta F., Morcillo-Suárez, Carlos, Malhotra, Sunny, Rio, Jordi, Leyva, Laura, Fernández, Oscar, Zettl, Uwe K., Killestein, Joep, Brassat, David, García-Merino, Juan Antonio, Sánchez, Antonio J., Urcelay, Elena, Alvarez-Lafuente, Roberto, Villar, Lusia M., Alvarez-Cermeño, Jose Carlos, Farré, Xavier, Lechner-Scott, Jeannette, Vandenbroeck, Koen, Rodríguez-Antigüedad, Alfredo, Drulovic, Jelena S., Martinelli Boneschi, Filippo, Chan, Andrew, Oksenberg, Jorge, Navarro, Arcadi, Montalban, Xavier, Comabella, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582905/ https://www.ncbi.nlm.nih.gov/pubmed/26445728 http://dx.doi.org/10.1212/NXI.0000000000000154

Ejemplares similares

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
por: Comabella, Manuel, et al.
Publicado: (2008)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
por: Gil-Varea, Elia, et al.
Publicado: (2018)

Metabolomic signatures associated with disease severity in multiple sclerosis
por: Villoslada, Pablo, et al.
Publicado: (2017)

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
por: de la Hera, Belén, et al.
Publicado: (2014)

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis
por: Ortiz, Miguel A., et al.
Publicado: (2015)

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis
por: Alcina, Antonio, et al.
Publicado: (2013)

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
por: Gil-Varea, Elia, et al.
Publicado: (2020)

Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis
por: de la Hera, Belén, et al.
Publicado: (2014)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
por: Mena, Jorge, et al.
Publicado: (2022)

Cell‐Based Therapies: The Nonresponder
por: Caplan, Arnold I.
Publicado: (2018)

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
por: Gómez-Fernández, Paloma, et al.
Publicado: (2020)

Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6
por: Swaminathan, Bhairavi, et al.
Publicado: (2013)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
por: Marín, Nieves, et al.
Publicado: (2014)

Patient Satisfaction Survey: Can Nonresponders be Ignored?
por: Garg, Pankaj K, et al.
Publicado: (2012)

Combining Multiple Hypothesis Testing with Machine Learning Increases the Statistical Power of Genome-wide Association Studies
por: Mieth, Bettina, et al.
Publicado: (2016)

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
por: Bustamante, Marta F., et al.
Publicado: (2013)

Liquid Biopsy in Neurological Diseases
por: Malhotra, Sunny, et al.
Publicado: (2023)

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
por: Leurs, CE, et al.
Publicado: (2019)

ANTIGEN BINDING AND CAPPING BY LYMPHOCYTES OF GENETIC NONRESPONDER MICE
por: Dunham, Edward K., et al.
Publicado: (1972)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Troubleshooting a Nonresponder: Guidance for the Strength and Conditioning Coach
por: Gleason, Benjamin H., et al.
Publicado: (2021)

Analysis of the Influencing Factors of Immunological Nonresponders in Wuhan, China
por: Lei, Enze, et al.
Publicado: (2022)

Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods
por: Baranzini, Sergio E, et al.
Publicado: (2005)

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients
por: Sadovnick, A. Dessa, et al.
Publicado: (2016)

Anodal Stimulation: An Underrecognized Cause of Nonresponders to Cardiac Resynchronization Therapy
por: Dendy, Khalin F, et al.
Publicado: (2011)

Practical Approaches to Treat ED in PDE5i Nonresponders
por: Cai, Zhonglin, et al.
Publicado: (2020)

Short‐term GAA loading: Responders versus nonresponders analysis
por: Ostojic, Sergej M.
Publicado: (2020)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
por: Meca-Lallana, J. E., et al.
Publicado: (2021)

Adaptive differentiation of murine lymphocytes. IV. (Responder × Nonresponder) F(1) T cells can be taught to preferentially help nonresponder,rather than responder, B cells
por: Katz, DH, et al.
Publicado: (1979)

Autophagic Marker MAP1LC3B Expression Levels Are Associated with Carotid Atherosclerosis Symptomatology
por: Swaminathan, Bhairavi, et al.
Publicado: (2014)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients
por: Segù, Marzia, et al.
Publicado: (2021)

Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis
por: Nattusamy, Loganathan, et al.
Publicado: (2017)

Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis
por: Tagirasa, Ravichandra, et al.
Publicado: (2020)

A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis
por: Espino-Paisán, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sf85l98vu0ct79iugmshgtd8o0